Sanara MedTech Inc. (SMTI)

Overview

Sanara MedTech Inc., a medical technology company based in Fort Worth, Texas, focuses on the development, marketing, and distribution of innovative surgical, wound, and skincare products and services. Catering to a wide range of healthcare settings, including physicians, hospitals, clinics, and post-acute care facilities across the United States, Sanara MedTech Inc. was founded in 2001. The company's mission revolves around enhancing patient outcomes and improving the quality of care in the wound and skin care sectors through its advanced medical technologies.

Products and Services

• CellerateRX Surgical: A medical hydrolysate of Type I bovine collagen, designed for the management of surgical, traumatic, and various wound types including partial- and full-thickness wounds, alongside first- and second-degree burns. It assists in creating an optimal environment for wound healing.
• HYCOL: Similar to CellerateRX Surgical in its base ingredient, HYCOL is a medical hydrolysate of Type I bovine collagen. It is intended for the management of a broad spectrum of wounds, such as full and partial thickness wounds, pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers, facilitating effective wound care solutions.
• BIAKOS Antimicrobial Skin and Wound Cleanser: A patented cleanser featuring synergistic ingredients proven to impact mature biofilm microbes. This product is tailored for cleaning wounds while combating biofilm-related complications.
• BIAKOS Antimicrobial Wound Gel: An antimicrobial hydrogel wound dressing designed to fight against planktonic microbes, immature, and mature biofilms, offering an advanced option for wound care.
• BIAKOS Antimicrobial Skin and Wound Irrigation Solution: Aimed at irrigating wounds, this solution works against a variety of microbes, aiding in the reduction of wound contamination and further complications.
• BIASURGE: A no-rinse surgical solution used for wound irrigation, developed to facilitate the cleansing process during surgical procedures, ensuring a clean wound environment precursory to healing.
• FORTIFY TRG: A freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet, geared towards reinforcing soft tissue where weakness exists, providing a scaffold for patient's tissue growth.
• FORTIFY FLOWABLE: An advanced wound care device, this extracellular matrix presents a flowable material for wound care, particularly useful in managing wounds that are difficult to dress.
• TEXAGEN: A multi-layer amniotic membrane allograft used as an anatomical barrier. It features robust handling character allowing it to be sutured for securement, offering a natural option for wound covering and protection.
• VIM Amnion Matrix: Serving as a homologous wound covering product, this is intended to mirror the natural wound healing processes of the body, promoting healing in a more natural manner.